FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 57 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,042,000 | -35.8% | 28,830 | -10.9% | 0.00% | -50.0% |
| Q4 2016 | $1,622,000 | -5.4% | 32,375 | -0.8% | 0.00% | 0.0% |
| Q3 2016 | $1,714,000 | -24.8% | 32,640 | -40.8% | 0.00% | -33.3% |
| Q2 2016 | $2,280,000 | -86.4% | 55,144 | -86.6% | 0.01% | -85.0% |
| Q1 2016 | $16,727,000 | -19.0% | 411,698 | -17.3% | 0.04% | -14.9% |
| Q4 2015 | $20,650,000 | +173.0% | 497,590 | +1.2% | 0.05% | +176.5% |
| Q3 2015 | $7,564,000 | -31.8% | 491,495 | +10.1% | 0.02% | -22.7% |
| Q2 2015 | $11,086,000 | +9.2% | 446,300 | +0.5% | 0.02% | +10.0% |
| Q1 2015 | $10,152,000 | -15.4% | 444,300 | 0.0% | 0.02% | -20.0% |
| Q4 2014 | $11,996,000 | +130.2% | 444,300 | 0.0% | 0.02% | +127.3% |
| Q3 2014 | $5,212,000 | -24.6% | 444,300 | 0.0% | 0.01% | -26.7% |
| Q2 2014 | $6,909,000 | -21.5% | 444,300 | -0.7% | 0.02% | -25.0% |
| Q1 2014 | $8,799,000 | +109.6% | 447,572 | +79.0% | 0.02% | +100.0% |
| Q4 2013 | $4,198,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|